Video
Author(s):
Deborah A. Bradley, MD, medical oncologist, Levine Cancer Institute, Atrium Health, discusses the importance of exercise in the management of prostate cancer treatment-related adverse events.
Deborah A. Bradley, MD, medical oncologist, Levine Cancer Institute, Atrium Health, discusses the importance of exercise in the management of prostate cancer treatment-related adverse events (AEs).
An area of prostate cancer that Bradley says needs more research is in terms of AE management for prostate cancer survivors. A lot of patients become very fatigued while undergoing therapy, and getting them up and exercising is an important way to overcome this. It is widely known that a common AE associated with chemotherapy is fatigue, but more work needs to be geared toward this. Bradley stressed that as therapy becomes more advanced, patient quality of life is a necessary important endpoint in clinical trials.
Additionally, as these therapies are moved into earlier settings, cardiac toxicity could become a factor. If a patient’s testosterone is being suppressed for such an extended period of time, researchers have to better understand the long-term AEs that could occur. Proper exercise regimens could be crucial here, as well.
Dr Caimi on Early Data for LMY-920 in R/R B-Cell NHL
Navigating a “Sea Change” in Frontline Urothelial Carcinoma Treatment
Dr Scalici on Data for IMNN-001 Plus SOC Chemotherapy in Advanced Ovarian Cancer
Dr Lin on the Safety of NKTR-255 in Enhancing Immune Recovery Post-Chemoradiation in Locally Advanced NSCLC
2 Commerce Drive
Cranbury, NJ 08512